ECOPHARMA AS
Score · fiscal year 2024
25of 100
How to read this: the company is ahead of 15 % of companies in the Morning class Micro in the same sector in 2024. What does this mean?
Rank in the Morning class Micro: 9,441 of 11,149 · What are Morning company classes?
Place in the whole sector: 19,344 of 22,333 · Handel
Profile
Beaver · Builder
Lower profitability, lower solidity
Position against comparable companies in 2024, not a verdict on the company. Based on profitability 43 and solidity 0 out of 100 among companies in the Morning class Micro in the same sector in 2024. Methodology
Against the sector
ECOPHARMA AS is 25 points below the median for companies in the Morning class Micro in the same sector in 2024.
Median score 50 among 11,142 companies.
Against companies in the Morning class Micro in the same sector in 2024: operating margin 1.9% (median 2.3%) and equity ratio −1.7% (median 35.1%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 5 MNOK | 4 MNOK |
| Operating margin | 1.9% | 2.3% |
| Profit margin | 1.8% | 1.9% |
| Return on assets | 1.5% | 5.6% |
| Equity ratio | −1.7% | 35.1% |
| Debt-to-equity | – | 1.22 |
| Current ratio | 0.40 | 1.76 |
| Revenue growth | – | 2.8% |
The median and “ahead of” refer to companies in the Morning class Micro in the same sector in 2024. The bar shows the share of companies the figure is ahead of.
With an index of 25, ECOPHARMA AS does better than 15% of companies in the Morning class Micro in the same sector (11,149 companies) in 2024.
Score 2023–2025
- ECOPHARMA AS
- Median: companies in the Morning class Micro in the same sector
What the numbers say
ECOPHARMA AS had an operating margin of 1.9% and an equity ratio of −1.7% in 2024, and ranks 19,344 of 22,333 in Handel.
From 2023 to 2024: went from a loss to a profit before tax and the equity ratio rose from −27.0% to −1.7%.
This text is generated automatically from the 2024 accounts.
Three simple methods
The methods give between 0 MNOK and 1 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 1 MNOK |
| EV/EBIT | 8.0 | 0 MNOK |
| P/B | 1.0 | not meaningful |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- critical
Equity is negative. How will it be rebuilt, and what do lenders and the auditor say about going concern?
Based on: Equity ratio −1.7% (median 35.1%).
- critical
Consider strengthening liquidity: current liabilities are 2.5 times current assets.
Based on: Current ratio 0.40 (median 1.76).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.1% of the debt in 2024. The policy rate averaged 4.50 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
- critical Negative equity
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of 1.5%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 43 | weight 30% |
|---|---|---|
| Solidity | 0 | weight 25% |
| Liquidity | 5 | weight 15% |
| Growth | – | no data, left out |
| Consistency | 52 | weight 15% |
Index version 2. Data completeness 85%: the share of the weights that had data.
Questions and answers
How profitable is ECOPHARMA AS?
The operating margin was 1.9% in 2024, against a median of 2.3% among companies in the Morning class Micro in the same sector. Return on assets was 1.5%.
How solid is ECOPHARMA AS?
The equity ratio was −1.7% in 2024 (median 35.1%). Equity is negative, so liabilities exceed assets.
What is the liquidity of ECOPHARMA AS like?
The current ratio was 0.40 in 2024 (median 1.76). Current assets did not cover current liabilities.
How does ECOPHARMA AS compare in Handel?
ECOPHARMA AS ranks 19,344 of 22,333 in Handel for 2024. Among companies in the Morning class Micro it is number 9,441 of 11,149.
From the Central Coordinating Register
- Org. no.
- 922710376
- Legal form
- AS
- Sector
- Handel (47.270)
- Morning company class
- Micro
- Employees
- 0–4 (not registered)
- Founded
- 26 March 2019 7 years in operation
- Share capital
- 0.03 MNOK
- Business address
- Lægreidsvegen 3, 5783 EIDFJORD
- Municipality
- Eidfjord rank 2 of 8 in KOSTRA group 17
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Tom Erik Landberg
- Chair of the board
- Tom Erik Landberg
- Board member
- Bjarne Brudeli
- Accountant
- VARDIS AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 26 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | – | 25 | 24 | |
| Rank | – | 19,344 | 20,302 | |
| Operating margin | – | 1.9% | −5.1% | |
| Return on assets | 0.0% | 1.5% | −5.2% | |
| Equity ratio | −27.0% | −1.7% | −6.7% | |
| Current ratio | 18.39 | 0.40 | 0.33 | |
| Revenue growth | – | – | 228.1% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | – | 5.0 MNOK | 16.3 MNOK |
| Operating profit | 0.0 MNOK | 0.1 MNOK | −0.8 MNOK |
| Profit before tax | 0.0 MNOK | 0.1 MNOK | −0.9 MNOK |
| Net profit | 0.0 MNOK | 0.1 MNOK | −1.0 MNOK |
| Financial expenses | – | 0.0 MNOK | 0.1 MNOK |
| Total assets | 0.7 MNOK | 6.1 MNOK | 16.0 MNOK |
| Current assets | 0.2 MNOK | 2.1 MNOK | 5.4 MNOK |
| Equity | −0.2 MNOK | −0.1 MNOK | −1.1 MNOK |
| Retained earnings | −0.2 MNOK | −0.1 MNOK | −1.1 MNOK |
| Total liabilities | 0.9 MNOK | 6.2 MNOK | 17.1 MNOK |
| Current liabilities | 0.0 MNOK | 5.3 MNOK | 16.5 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 26 October 2026, accounts id 6328645.
Further
Similar companies
- CAR4YOU AS index 25, rank 19,337 · compare
- THOMAS LEKER SANDVIKA AS index 25, rank 19,339 · compare
- ONSØY SYNSSENTER AS index 25, rank 19,341 · compare
- DCO SCANDINAVIA AS index 25, rank 19,346 · compare
- SEDICON AS index 25, rank 19,347 · compare